Loading...
Market
Will a phase III trial for the new fertility drug be published by July 31, 2025?
3
Resolution / Starting Odds
Yes • 50%
No • 50%
Scientific journals and publications
Story
New Fertility Drug Boosts IVF Success Rates by 20%, Live Births by 7%
Jul 8, 2024, 08:25 AM
A new fertility drug has shown promising results in increasing the success rates of in vitro fertilization (IVF) and intracytoplasmic sperm injection (ICSI). The drug, which is simple to take and non-hormonal, was tested in a phase II trial involving 96 infertile women aged 40 and under. The study found that the drug can boost the chances of pregnancy by 20%, and could lead to a 7% increase in live births after IVF. This development offers hope for childless couples struggling with the high costs and emotional toll of IVF treatments.
View original story
Similar markets
Yes • 50%
No • 50%
Yes • 50%
No • 50%
Yes • 50%
No • 50%
Yes • 50%
No • 50%
Yes • 50%
No • 50%
Yes • 50%
No • 50%
Yes • 50%
No • 50%
Positive results for B-cell malignancies • 25%
Positive results for autoimmune diseases • 25%
Negative results for both • 25%
Mixed results • 25%
